Treating depression in HIV/AIDS

South African Journal of Psychiatry

Volumn 13, Issue 3, 2007, Pages 86-88

  Moosa, M Y H ^a   Jeenah, F Y ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; FLUOXETINE; IMIPRAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTICHOLINERGIC EFFECT; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MYALGIA; PREVALENCE; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SOCIOECONOMICS; UNSPECIFIED SIDE EFFECT; VIRUS LOAD; XEROSTOMIA;

EID: 35248850222     PISSN: 16089685     EISSN: None     Source Type: Journal    
DOI: 10.4102/sajpsychiatry.v13i3.20     Document Type: Review

References (38)

1. National HIV and Syphilis Antenatal Seroprevalence Survey in South Africa 2004. Pretoria: Department of Health, 2005. http://www.doh.gov.za/ docs/(last accessed 14 June 2006).
2. UNAIDS and World Health Organization (WHO). AIDS Epidemic Update: December 2004. Geneva: UNAIDS/WHO, 2004: 1.
3. Barry KL, Fleming MF, Manwell LB, et al. Prevalence of and factors associated with current and lifetime depression in older adult primary care patients. Fam Med 1998; 30: 366-371.
4. Steffens DC, Skoog I, Norton MC, et al. Prevalence of depression and its treatment in an elderly population: The Cache County study. Arch Gen Psychiatry 2000; 57: 601-607.
5. Feldman E, Moyou R, Hawton K, et al. Psychiatric disorder in medical in-patients. Q J Med 1987; 63: 405-412.
6. Olley BO, Seedat S, Stein DJ. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res 2006; 61: 479-484.
7. Zibler C. Psychotherapeutic strategies for coping with HIV infection. In: Cournos F, Forstein M, eds. What Mental Health Practitioners Need to Know About HIV and AIDS. San Francisco: Jossey-Bass, 2000: 51-56.
8. Maj M, Jonssen R, Starace F, et al. WHO neuropsychiatric AIDS study, cross-sectional phase I: study design and psychiatric findings. Arch Gen Psychiatry 1994; 51: 39-49.
9. Yun LWH, Maravi, M., Kobayashi, et al. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38: 432-438.
10. Maj M. Depressive syndromes and symptoms in subjects with human immunodeficiency virus (HIV) infection. Br J Psychiatry 1996; 30: 117-122.
11. Lyketsos CG, Hanson A, Fishman M, et al. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med 1994; 24: 103-113.
12. Goggin K, Engelson ES, Rabkin JG, et al. The relationship of mood, endocrine, and sexual disorders in human immunodeficiency virus positive (HIV+) women: an exploratory study. Psychosom Med 1998; 60: 11-16.
13. Taylor ER, Amodei N, Mangos R. The presence of psychiatric disorders in HIV-infected women. Journal of Counseling and Development 1996; 74: 345-351.
14. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA 2001; 285: 1466-1474.
15. Moore J, Schuman P, Schoenbaum E, et al. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS 1999; 13: 2459-2468.
16. Fukunishi I, Matsumoto T, Negishi M, et al. Somatic complaints associated with depressive symptoms in HIV-positive patients. Psychother Psychosom 1997; 66: 248-251.
17. Dew MA, Becker JT, Sonchez J, et al. Prevalence and predictors of depressive, anxiety, and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med 1997; 27: 395-409.
18. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158: 725-730.
19. Gill D. Do antidepressants work in depression in physical illness? Proceedings of Academy of Psychosomatic Medicine 44th Annual Meeting, Chicago, 6-10 November 1997: 37-38.
20. Elliolt AJ, Roy-Byrne PP. Major depressive disorder and HIV-1 infection: A review of treatment trials. Semin Clin Neuropsychiatry 1998; 3: 137-150.
21. Markowitz J, Kocsis JH, Fishman B, et al. Treatment of depressive symptoms in HIV-positive patients. Arch Gen Psychiatry 1998; 55: 452-457.
22. Rabkin JG, Wagner G, Rabkin R. Effects of sertraline on mood and immune status in patients with depression and HIV illness. J Clin Psychiatry 1994; 55: 433-439.
23. Zisook S, Peterkin J, Goggin KJ, et al. Treatment of major depression in HIV-seropositive men. J Clin Psychiatry 1998; 59: 217-224.
24. Elliott AJ, Uldall KK, Bergam K, et al. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Am J Psychiatry 1998; 155: 367-372.
25. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm 2000; 57: 376-386.
26. Starace F. Epidemiology of suicide among persons with AIDS. AIDS Care 1995; 7: S123-S128.
27. Goodkin K, Feaster DJ, Asthana D, et al. A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visits. Clin Diagn Lab Immunol 1998; 5: 382-391.
28. Gregerson MB, Roberts IM, Amiri MM. Absorption and imagery locate immune response in the body. Biofeedback & Serf Regulation 1996; 21: 149-165.
29. Markowitz JC, Klerman GL, Perry SW. Interpersonal psychotherapy of depressed HIV positive outpatients. Hospital & Community Psychiatry 1992; 43: 885-890.
30. Schleifer SJ, Keller SE, Bartlett JA. Depression and immunity: clinical factors and therapeutic course. Psychiatry Res 1999; 85: 63-69.
31. Frank MG, Hendricks SE, Johnson DR, et al. Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 1997; 39: 18-24.
32. Slein M, Miller A, Treisman R. Depression, the immune system, and health and illness: findings in search of meaning. Arch Gen Psychiatry 1991; 48: 171-177.
33. Moyne TJ, Vittinghoff E, Chesney M, et al. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med 1996; 156: 2233-2238.
34. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. Updated recommendations of the International AIDS Society - USA Panel. JAMA 1998; 280: 78-86.
35. Stephenson J. AIDS researchers target poor adherence. JAMA 1999; 281: 1069.
36. Wainberg MA. Friedlang G. Public health implications of anti-retroviral therapy and HIV drug resistance. JAMA 1998; 279; 1977-1983.
37. Paterson D, Swindells S, Morh J, et al. Adherence to prolease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21-30.
38. Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected palients to antiretroviral therapy. Clin Infect Dis 1999; 29: 824-830.